全文获取类型
收费全文 | 20162篇 |
免费 | 1423篇 |
国内免费 | 92篇 |
专业分类
耳鼻咽喉 | 309篇 |
儿科学 | 603篇 |
妇产科学 | 419篇 |
基础医学 | 2871篇 |
口腔科学 | 473篇 |
临床医学 | 1837篇 |
内科学 | 4587篇 |
皮肤病学 | 604篇 |
神经病学 | 1954篇 |
特种医学 | 656篇 |
外国民族医学 | 1篇 |
外科学 | 2322篇 |
综合类 | 152篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 1903篇 |
眼科学 | 372篇 |
药学 | 1365篇 |
1篇 | |
中国医学 | 53篇 |
肿瘤学 | 1188篇 |
出版年
2023年 | 148篇 |
2022年 | 113篇 |
2021年 | 526篇 |
2020年 | 330篇 |
2019年 | 526篇 |
2018年 | 620篇 |
2017年 | 407篇 |
2016年 | 405篇 |
2015年 | 503篇 |
2014年 | 692篇 |
2013年 | 906篇 |
2012年 | 1361篇 |
2011年 | 1304篇 |
2010年 | 758篇 |
2009年 | 655篇 |
2008年 | 1053篇 |
2007年 | 1091篇 |
2006年 | 1010篇 |
2005年 | 1025篇 |
2004年 | 953篇 |
2003年 | 849篇 |
2002年 | 756篇 |
2001年 | 410篇 |
2000年 | 360篇 |
1999年 | 361篇 |
1998年 | 141篇 |
1997年 | 126篇 |
1996年 | 106篇 |
1995年 | 121篇 |
1994年 | 83篇 |
1993年 | 109篇 |
1992年 | 236篇 |
1991年 | 231篇 |
1990年 | 210篇 |
1989年 | 252篇 |
1988年 | 202篇 |
1987年 | 194篇 |
1986年 | 198篇 |
1985年 | 197篇 |
1984年 | 144篇 |
1983年 | 162篇 |
1982年 | 92篇 |
1981年 | 88篇 |
1980年 | 89篇 |
1979年 | 155篇 |
1978年 | 102篇 |
1974年 | 94篇 |
1972年 | 87篇 |
1971年 | 84篇 |
1969年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 295 毫秒
1.
2.
Amandeep R. Mahal Laura D. Cramer Elyn H. Wang Shiyi Wang Amy J. Davidoff Cary P. Gross James B. Yu 《Journal of Geriatric Oncology》2021,12(1):102-105
ObjectivesAlthough survival after a cancer diagnosis has improved considerably over the past 20 years, little is known about trends in health-related quality-of-life (HRQOL) for older prostate, breast, and lung cancer survivors.MethodsUsing a population-based registry with longitudinal patient reported outcomes (the National Cancer Institute Surveillance, Epidemiology and End Results database linked to Medicare Health Outcomes Survey), we analyzed Medicare Advantage patients diagnosed with cancer during 1998–2011, who completed surveys regarding HRQOL through 2013. ‘Early Era’ patients were treated during 1998–2003; ‘Late Era’ patients were treated during 2006–2011. After propensity score matching, post-diagnosis changes in health utility (HU), Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were calculated and compared between the two eras.ResultWe identified 208 older patients with prostate, 276 with breast and 76 with lung cancer who were treated in the ‘Early Era’ and matched to equal numbers in the ‘Late Era’. Mean age of patients in early and late era was 72 and 73 years, respectively. The mean post-diagnosis decline in health utility for patients treated in the ‘Late Era’ was not significantly different from the ‘Early Era’ for any cancer (Prostate [early vs. late]: ?0.06 vs. -0.03, p = .09; Breast: ?0.03 vs. ?0.04, p = .65; Lung: ?0.07 vs. ?0.07, p = .95); nor for Physical Component Summary or Mental Component Summary scores.ConclusionOlder patients treated for prostate, breast or lung cancer in the later era reported similar outcomes of changes in HRQOL compared to earlier era patients. 相似文献
3.
Stephanie H. Ameis John D. Haltigan Rachael E. Lyon Amanda Sawyer Pat Mirenda Connor M. Kerns Isabel M. Smith Tracy Vaillancourt Joanne Volden Charlotte Waddell Lonnie Zwaigenbaum Teresa Bennett Eric Duku Mayada Elsabbagh Stelios Georgiades Wendy J. Ungar Anat Zaidman-Zait Meng-Chuan Lai Peter Szatmari for the Pathways in ASD Study Team 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(5):553-562
4.
Li Sun Zia Sadique Isabel dos-Santos-Silva Li Yang Rosa Legood 《International journal of cancer. Journal international du cancer》2019,144(10):2596-2604
In low and middle-income countries mammographic breast cancer screening is prohibitively expensive and a cheaper alternative option is to use ultrasound as the primary screening test. In 2009, China launched a breast cancer screening programme for rural women aged 35–64 years with clinical breast examination coupled with ultrasound as the primary tool. Our study aimed to analyse the cost-effectiveness of breast screening compared to no screening among Chinese rural women. We developed a Markov model to estimate the lifetime costs and effects for rural women aged 35 years from a societal perspective. Asymptomatic women in the intervention arm were screened every 3 years before age 64 years. Breast cancer in the non-screening arm can only be diagnosed on presentation of symptoms. Parameter uncertainty was explored using one-way and probabilistic sensitivity analyses. Compared to no screening, breast cancer screening cost $186.7 more and led to a loss of 0.20 quality-adjusted life years (QALYs). Breast screening was more expensive and did harm to health among rural women with an incremental cost-effectiveness ratio (ICER) of $-916/QALY. The sensitivity analysis identified utility loss from false positives as the factor that most influenced the results, but this did not affect the conclusions. In a rural setting with such low breast cancer incidence, screening for asymptomatic disease is not cost-effective with current screening tools. Priority should be given to ensure that symptomatic women have proper access to diagnosis and treatment at an early stage as this will lead to mortality reductions without the usual screening harms. 相似文献
5.
Sonia Moreno-Grau Itziar de Rojas Isabel Hernández Inés Quintela Laura Montrreal Montserrat Alegret Begoña Hernández-Olasagarre Laura Madrid Antonio González-Perez Olalla Maroñas Maitée Rosende-Roca Ana Mauleón Liliana Vargas Asunción Lafuente Carla Abdelnour Octavio Rodríguez-Gómez Silvia Gil Miguel Ángel Santos-Santos Agustín Ruiz 《Alzheimer's & dementia》2019,15(10):1333-1347
IntroductionLarge variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways.MethodsGenome Research at Fundacio ACE ([email protected]) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, [email protected] series were meta-analyzed with additional genome-wide association study data sets.ResultsWe classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444.DiscussionThe regulation of vasculature is a prominent causal component of probable AD. [email protected] meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series. 相似文献
6.
7.
8.
9.
10.